Targeted Delivery of the PKMYT1 Inhibitor RP-6306 Mediates PANoptosis in Pancreatic Cancer via Mitotic Catastrophe

Treatment with the PKMYT1 inhibitor RP-6306 promotes rapid mitotic entry, resulting in DNA damage and mitotic catastrophe, thereby inducing PANoptosis.